ClinicalTrials.govpublic full text
An Observational Study of Upadacitinib to Assess Change in Disease Activity in Canadian Adult Participants With Moderate-to-Severe Atopic Dermatitis Who Are Inadequate Responders To or Discontinuing Dupilumab
atopic dermatitis, atopic dermatitis (ad), upadacitinib, rinvoq, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 912318
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.